Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • News & Views
  • Published:

Progress in cardiovascular biology: PPAR for the course

Studies on mice lacking the peroxisome proliferator-activated receptor (PPAR) suggest that PPAR ligands reduce lipid accumulation in foamy macrophages, and may target other receptors. These findings warrant an in-depth investigation into the gene regulatory mechanisms of PPAR ligands, which are currently being developed as drugs to treat atherosclerosis and diabetes. (pages 41–47)

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Figure 1: Activation of PPAR-γ in foamy macrophages increases net lipid efflux.

References

  1. Rangwala, S.M. & Lazar, M.A. Transcriptional control of adipogenesis. Ann. Rev. Nutr. 8, 535–559 (2000).

    Article  Google Scholar 

  2. Ricote, M., Li, A.C., Willson, T.M., Kelly, C.J. & Glass, C.K. The peroxisome proliferator-activated receptor-γ is a negative regulator of macrophage activation. Nature 391, 79–82 (1998).

    Article  CAS  Google Scholar 

  3. Tontonoz, P., Nagy, L., Alvarez, J.G., Thomazy, V.A. & Evans, R.M. PPAR-γ promotes monocyte/macrophage differentiation and uptake of oxidized LDL. Cell 93, 241–252 (1998).

    Article  CAS  Google Scholar 

  4. Moore, K.J. et al. Role of PPAR-γ in macrophage differentiation and cholesterol uptake. Nature Med. 7, 41–47 (2000).

    Article  Google Scholar 

  5. Chawla, A. et al. Generation of PPAR-γ null macrophages reveals role in regulation of gene expression linked to lipid metabolism but not inflammation. Nature Med. 7, 48–52 (2000).

    Article  Google Scholar 

  6. Chinetti, G. et al. PPAR-α and PPAR-γ activators induce cholesterol removal from human macrophage foam cells through stimulation of the ABCA1 pathway. Nature Med. 7, 53–58 (2000).

    Article  Google Scholar 

  7. Olefsky, J.M. Treatment of insulin resistance with peroxisome proliferator-activated receptor-γ agonists. J. Clin. Invest. 106, 467–472 (2000).

    Article  CAS  Google Scholar 

  8. Seed, B. PPAR-γ and colorectal carcinoma: conflicts in a nuclear family. Nature Med. 4, 1004–10005 (1998).

    Article  CAS  Google Scholar 

  9. Nagy, L., Tontonoz, P., Alvarez, J.G., Chen, H. & Evans, R.M. Oxidized LDL regulates macrophage gene expression through activation of PPAR-γ. Cell 93, 229–240 (1998).

    Article  CAS  Google Scholar 

  10. Jiang, C., Ting, A.T. & Seed, B. PPAR-γ agonists inhibit production of monocyte inflammatory cytokines. Nature 391, 82–86 (1998).

    Article  CAS  Google Scholar 

  11. Rosen, E.D. & Spiegelman, B.M. Peroxisome proliferator-activated receptor-γ ligands and atherosclerosis: ending the heartache. J. Clin. Invest. 106, 629–631 (2000).

    Article  CAS  Google Scholar 

  12. Rossi, A. et al. Anti-inflammatory cyclopentenone prostaglandins are direct inhibitors of IκB kinase. Nature 403, 103–108 (2000).

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Lazar, M. Progress in cardiovascular biology: PPAR for the course. Nat Med 7, 23–24 (2001). https://doi.org/10.1038/83301

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1038/83301

This article is cited by

Search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing